STRS Ohio’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$522K Sell
2,666
-4
-0.1% -$777 ﹤0.01% 1060
2025
Q4
$463K Buy
2,670
+5
+0.2% +$910 ﹤0.01% 1138
2025
Q3
$508K Sell
2,665
-15,056
-85% -$2.67M ﹤0.01% 1085
2025
Q2
$3.18M Buy
17,721
+1,968
+12% +$342K 0.01% 548
2025
Q1
$2.67M Sell
15,753
-7,591
-33% -$1.25M 0.01% 543
2024
Q4
$3.52M Buy
23,344
+8,310
+55% +$1.29M 0.01% 522
2024
Q3
$2.33M Sell
15,034
-2,757
-15% -$412K 0.01% 579
2024
Q2
$2.44M Buy
+17,791
New +$2.44M 0.01% 551
2024
Q1
Sell
-16,270
Closed -$2.24M 1948
2023
Q4
$2.24M Buy
16,270
+1,150
+8% +$151K 0.01% 558
2023
Q3
$1.84M Sell
15,120
-781
-5% -$104K 0.01% 629
2023
Q2
$2.23M Sell
15,901
-2,044
-11% -$282K 0.01% 577
2023
Q1
$2.54M Sell
17,945
-2,594
-13% -$371K 0.01% 550
2022
Q4
$3.21M Buy
20,539
+3,076
+18% +$442K 0.01% 523
2022
Q3
$2.14M Buy
17,463
+1,618
+10% +$213K 0.01% 569
2022
Q2
$2.11M Sell
15,845
-2,799
-15% -$381K 0.01% 597
2022
Q1
$2.55M Buy
18,644
+1,144
+7% +$159K 0.01% 621
2021
Q4
$3.03M Buy
17,500
+79
+0.5% +$12K 0.01% 590
2021
Q3
$2.53M Buy
17,421
+13,979
+406% +$2.05M 0.01% 605
2021
Q2
$454K Sell
3,442
-118
-3% -$15.4K ﹤0.01% 1590
2021
Q1
$456K Sell
3,560
-40,435
-92% -$4.98M ﹤0.01% 1608
2020
Q4
$5.24M Buy
43,995
+1,033
+2% +$126K 0.02% 466
2020
Q3
$4.92M Sell
42,962
-1,644
-4% -$194K 0.02% 461
2020
Q2
$5.08M Buy
44,606
+21,308
+91% +$2.26M 0.02% 438
2020
Q1
$1.87M Sell
23,298
-6,788
-23% -$703K 0.01% 582
2019
Q4
$3.21M Buy
30,086
+7,808
+35% +$814K 0.01% 569
2019
Q3
$2.38M Buy
22,278
+1,742
+8% +$179K 0.01% 615
2019
Q2
$2.09M Buy
20,536
+1,017
+5% +$97.7K 0.01% 645
2019
Q1
$1.75M Sell
19,519
-1,036
-5% -$89.8K 0.01% 672
2018
Q4
$1.71M Sell
20,555
-143
-0.7% -$13.4K 0.01% 656
2018
Q3
$2.23M Buy
20,698
+1,668
+9% +$183K 0.01% 634
2018
Q2
$2.09M Buy
19,030
+2,903
+18% +$302K 0.01% 644
2018
Q1
$1.62M Buy
16,127
+388
+2% +$39.7K 0.01% 682
2017
Q4
$1.55M Sell
15,739
-3,214
-17% -$305K 0.01% 679
2017
Q3
$1.77M Buy
18,953
+514
+3% +$54.6K 0.01% 655
2017
Q2
$2.05M Sell
18,439
-7,775
-30% -$822K 0.01% 624
2017
Q1
$2.57M Sell
26,214
-4,117
-14% -$392K 0.01% 611
2016
Q4
$2.79M Sell
30,331
-6,003
-17% -$517K 0.01% 598
2016
Q3
$3.07M Sell
36,334
-2,554
-7% -$214K 0.01% 584
2016
Q2
$3.17M Buy
38,888
+457
+1% +$34.8K 0.01% 568
2016
Q1
$2.75M Sell
38,431
-2,184
-5% -$146K 0.01% 581
2015
Q4
$2.89M Buy
40,615
+647
+2% +$43.5K 0.01% 578
2015
Q3
$2.46M Buy
39,968
+5,948
+17% +$416K 0.01% 603
2015
Q2
$2.47M Buy
34,020
+27,032
+387% +$2M 0.01% 615
2015
Q1
$537K Buy
6,988
+392
+6% +$28.1K ﹤0.01% 1174
2014
Q4
$442K Hold
6,596
﹤0.01% 1237
2014
Q3
$400K Hold
6,596
﹤0.01% 1273
2014
Q2
$387K Hold
6,596
﹤0.01% 1291
2014
Q1
$382K Hold
6,596
﹤0.01% 1263
2013
Q4
$353K Sell
6,596
-298,200
-98% -$17.7M ﹤0.01% 1293
2013
Q3
$18.8M Sell
304,796
-35,912
-11% -$2.15M 0.08% 305
2013
Q2
$20.7M Buy
+340,708
New +$20.3M 0.09% 288

Other funds holding DGX

STRS Ohio's DGX Position: Q1 2026 in Review

STRS Ohio reduced its Quest Diagnostics (DGX) stake by 0.15% in Q1 2026, selling an estimated $777 and leaving 2,666 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

STRS Ohio first reported a position in DGX in Q2 2013 and has held it in 51 quarters since. The position peaked at $20.7M in Q2 2013. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • STRS Ohio held 2,666 shares of Quest Diagnostics worth $522K as of Q1 2026.
  • STRS Ohio sold 4 Quest Diagnostics shares in Q1 2026, an estimated $777.
  • Quest Diagnostics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1060 holding.
  • STRS Ohio first reported a position in Quest Diagnostics in Q2 2013 and has held it in 51 quarters since.
  • STRS Ohio's Quest Diagnostics position peaked at $20.7M in Q2 2013.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.